Key statistics
As of last trade Mirum Pharmaceuticals Inc (08D:STU) traded at 41.40, -9.21% below its 52-week high of 45.60, set on Nov 14, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 40.60 |
---|---|
High | 41.40 |
Low | 40.60 |
Bid | 40.80 |
Offer | 42.20 |
Previous close | 39.00 |
Average volume | 260.22 |
---|---|
Shares outstanding | 47.71m |
Free float | 46.51m |
P/E (TTM) | -- |
Market cap | 2.07bn USD |
EPS (TTM) | -2.12 USD |
Data delayed at least 15 minutes, as of Nov 21 2024.
More ▼
Press releases
- Mirum Pharmaceuticals to Showcase Data from its LIVMARLI and Volixibat Clinical Programs at AASLD’s The Liver Meeting
- Mirum Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update
- Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Mirum Pharmaceuticals to Participate in Upcoming Investor Conferences
- Mirum Pharmaceuticals to Announce Third Quarter 2024 Financial Results and Host Conference Call on November 12, 2024
- Mirum Pharmaceuticals to Showcase LIVMARLI Data from its ALGS and PFIC Programs at the NASPGHAN Annual Meeting
- Volixibat Granted Breakthrough Therapy Designation for Cholestatic Pruritus in Primary Biliary Cholangitis
More ▼